A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand.

scientific article published on 13 June 2007

A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1017/S1041610207005583
P698PubMed publication ID17565765

P2093author name stringYuichi Hirose
Michael Woodward
Terry Mitchell
P2860cites workBlood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaQ24246379
Neuropathologic features of amnestic mild cognitive impairmentQ28238965
Mild cognitive impairment as a diagnostic entityQ29619568
Age-related memory decline: current concepts and future directionsQ34187606
Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Q34244667
Vitamin E and donepezil for the treatment of mild cognitive impairmentQ34411313
Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful.Q35472824
Disclosing a diagnosis of dementia: a systematic reviewQ35646972
Anthropological contributions to the understanding of age-related cognitive impairmentQ36104979
Neuropathology of older persons without cognitive impairment from two community-based studiesQ38405842
FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairmentQ38416277
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up studyQ40349700
Regulatory authorities review use of galantamine in mild cognitive impairmentQ42789972
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular diseaseQ44438340
A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairmentQ45292749
Sixteen-year longitudinal and time lag changes in memory and cognition in older adultsQ46228215
Neuropathologic outcome of mild cognitive impairment following progression to clinical dementiaQ48550309
Mild cognitive impairment: is it Alzheimer's disease or not?Q48813562
Incidence and outcome of mild cognitive impairment in a population-based prospective cohort.Q50710981
Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.Q50758048
Living wills and the Mental Capacity Act: a postal questionnaire survey of UK geriatricians.Q51922310
Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.Q51930296
Mild cognitive impairment, amnestic type: an epidemiologic study.Q51939291
Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.Q51939293
Selective decline in memory function among healthy elderly.Q52034186
Neurologic function in the optimally healthy oldest old. Neuropsychological evaluation.Q52060808
Mild cognitive impairment (MCI) represents early-stage Alzheimer's disease.Q53270841
Mild cognitive impairmentQ57306293
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam StudyQ57782154
Classification criteria for mild cognitive impairment: a population-based validation studyQ73371507
A survey of attitudes and knowledge of geriatricians to driving in elderly patientsQ77324462
FITTING MULTIVARIATE MODELS TO COMMUNITY DATA: A COMMENT ON DISTANCE-BASED REDUNDANCY ANALYSISQ104204719
P433issue1
P921main subjectAustraliaQ408
New ZealandQ664
mild cognitive impairmentQ1472703
cognitive dysfunctionQ57859955
P304page(s)77-85
P577publication date2007-06-13
P1433published inInternational PsychogeriatricsQ15761572
P1476titleA survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand.
P478volume20

Reverse relations

cites work (P2860)
Q50740755Attitudes of UK psychiatrists to the diagnosis of MCI in clinical practice.
Q99208504Biomarker counselling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment: A European Alzheimer´s Disease Consortium survey
Q38749838Cancer-induced cognitive impairment: practical solutions to reduce and manage the challenge
Q36653357Caring for older adults with mild cognitive impairment: an update for nurses.
Q36680478Community-dwelling older adults with memory loss: needs assessment
Q34135724Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
Q85951092Familiarity, knowledge, and preferences of family physicians regarding mild cognitive impairment
Q40890218Five ethical questions involving Alzheimer's disease.
Q34053221Mild cognitive impairment in clinical care: a survey of American Academy of Neurology members
Q37396071Screening for mild cognitive impairment: a systematic review
Q48124401The Sydney Memory and Ageing Study (MAS): methodology and baseline medical and neuropsychiatric characteristics of an elderly epidemiological non-demented cohort of Australians aged 70-90 years

Search more.